Skip to main content
Livermore
Livermore
ZHEN

Natixis

SEC CIK
0001274981
Latest filing
Aug 13, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
183,344
Value
$16.6M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by Natixis, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026183,344$16.6M0.1%−110,329−37.6%ReducedHolders
Q1 2026293,673$23.5M0.1%−21,850−6.9%ReducedHolders
Q4 2025315,523$26.9M0.1%−10,891−3.3%ReducedHolders
Q3 2025326,414$25.4M0.1%+12,031+3.8%AddedHolders
Q2 2025314,383$24.6M0.1%+84,139+36.5%AddedHolders
Q1 2025230,244$16.6M0.1%−15,967−6.5%ReducedHolders
Q4 2024246,211$18.2M0.1%+112,637+84.3%AddedHolders
Q3 2024133,574$8.81M0.1%−262,631−66.3%ReducedHolders
Q2 2024396,205$36.6M0.2%+293,904+287.3%AddedHolders
Q1 2024102,301$9.78M0.1%−96,945−48.7%ReducedHolders
Q4 2023199,246$15.2M0.1%−358,814−64.3%ReducedHolders
Q3 2023558,060$38.7M0.3%+275,029+97.2%AddedHolders
Q2 2023283,031$26.7M0.2%+222,318+366.2%AddedHolders
Q1 202360,713$5.02M<0.1%−102,984−62.9%ReducedHolders
Q4 2022163,697$12.2M0.1%+7,121+4.5%AddedHolders
Q3 2022156,576$13.1M0.1%+106,122+210.3%AddedHolders
Q2 202250,454$4.80M<0.1%−42,180−45.5%ReducedHolders
Q1 202292,634$10.9M<0.1%+72,397+357.7%AddedHolders
Q4 202120,237$2.62M<0.1%−9,681−32.4%ReducedHolders
Q3 202129,918$3.39M<0.1%−10,277−25.6%ReducedHolders
Q2 202140,195$4.16M<0.1%−75,721−65.3%ReducedHolders
Q1 2021115,916$9.70M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.